ETON
Eton Pharmaceuticals, Inc.
A maker of rare-disease treatments for children and adults, Eton Pharmaceuticals markets FDA-approved products including INCRELEX for growth disorders and ALKINDI SPRINKLE, a first-of-its-kind granular hydrocortisone for kids with adrenal insufficiency. Born in 2017 as a spinoff from Imprimis Pharmaceuticals, the Deer Park, Illinois company reworks existing medicines into friendlier forms—like a needle-free ZENEO autoinjector that blasts an emergency dose through the skin in a fraction of a second.
CUSIP: 29772L108HealthcareUS1 holder
Total Value
$1.64M
Total Shares
45.4K
Net Share Change
+15.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
